Safety and efficacy of naldemedine in cancer patients with opioid-induced constipation: a pooled, subgroup analysis of two randomised controlled studies.

Osaka, Iwao; Ishiki, Hiroto; Yokota, Takaaki; Tada, Yukio; Sato, Hiroki; Okamoto, Masaharu; Satomi, Eriko

Osaka, Iwao; Ishiki, Hiroto; Yokota, Takaaki; Tada, Yukio; Sato, Hiroki; Okamoto, Masaharu; Satomi, Eriko.

Afiliación

Osaka I; Department of Palliative Care, HITO Medical Center, Shikokuchuo City, Ehime, Japan.
Ishiki H; Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan.
Yokota T; Department of Global Development, Shionogi & Co, Ltd, Osaka, Japan.
Tada Y; Department of Global Development, Shionogi & Co, Ltd, Osaka, Japan.
Sato H; Department of Medical Affairs, Shionogi & Co, Ltd, Osaka, Japan.
Okamoto M; Department of Medical Affairs, Shionogi & Co, Ltd, Osaka, Japan.
Satomi E; Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan.

ESMO Open ; 4(4): e000527, 2019.

Article en En | MEDLINE | ID: mdl-31423335

Palabras clave

cancer pain; naldemedine; opioid-induced constipation; spontaneous bowel movement; subgroup analysis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: ESMO Open Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google